Mantra Bio

Mantra Bio is developing a new generation of targeted therapies based on its proprietary platform, designing Targeted Exosome Vehicles (TEVs). The company’s REVEAL™ platform integrates computational biology, wet lab biology, and automation technologies to leverage the diversity of exosomes for the rational design of therapeutics targeting various tissues and cell types. Mantra Bio has also established scalable biomanufacturing processes and related technologies to ensure the reproducible production of this novel class of therapies with high purity. The company’s strategy is to build a therapeutic pipeline both in-house and through partnerships. Its initial product portfolio includes engineered exosome therapies in the fields of ophthalmology and infectious diseases.